Human schistosomiasis: potential long term consequences of vaccination programmes

By Chan M.-S.   Woolhouse M.E.J.   Bundy D.A.P.  

Vaccine, Vol. 15, Iss. 14, 1997-10 ,pp. : 1545-1550

Elsevier

Access to resources Recommend Favorite

Estimating the potential health gain and cost consequences of introducing a pre-school DTPa pertussis booster into the UK child vaccination schedule

By Stevenson M.   Beard S.   Finn A.   Brennan A.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1778-1786

Elsevier

Access to resources Recommend Favorite

Mucosal vaccination against schistosomiasis using liposome-associated Sm 28 kDa glutathione S-transferase

By Ivanoff N.   Phillips N.   Schacht A.-M.   Heydari C.   Capron A.   Riveau G.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1123-1131

Elsevier

Access to resources Recommend Favorite

The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales

By Edmunds W.J.   Brisson M.   Rose J.D.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3076-3090

Elsevier

Access to resources Recommend Favorite

The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales

By Edmunds W.J.   Brisson M.   Melegaro A.   Gay N.J.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1316-1330

Elsevier

Access to resources Recommend Favorite